mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.17 |
0.0005 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.19 |
0.0006 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |